03 Sep CHO PLUS
Lawrence Forman, Founder and CEO
Oct. 7 | 5:00pm | FLW Ballroom G
South San Francisco, CA
CHO Plus, Inc. is a privately held company founded in 2014 with the mission of increasing the productivity of mammalian cells used for manufacturing life-saving therapeutic agents for treating human disease. CHO Plus has patents granted and pending for several different technologies in over ten jurisdictions around the world. Currently CHO Plus studies demonstrate that our engineered CHO cells produce up to 10-fold more therapeutic antibodies than un-engineered cells and our engineered HEK-293 cells produce up to 20-fold AAV vectors, with up to 55% full capsids before purification. With a focus on innovation and collaboration, the company is committed to advancing the production of therapeutic proteins and gene therapy vectors to address a wide range of clinical indications.
